What is MSI Methylation Sciences?
MSI Methylation Sciences is a company operating within the life sciences sector, focusing on methylation-related technologies. While the provided description details a media and lottery operator, it is extraneous to MSI Methylation Sciences' core business. The company's focus on methylation science suggests a specialization in areas such as epigenetics, diagnostics, or therapeutics, leveraging the biological process of DNA methylation to develop novel solutions. The recent major strategic investment indicates a potential for scaling operations, advancing research and development, or expanding market reach within its specialized field.
How much funding has MSI Methylation Sciences raised?
MSI Methylation Sciences has raised a total of $30M across 1 funding round:
Private Equity
$30M
Private Equity (2016): $30M with participation from Quark Venture
Key Investors in MSI Methylation Sciences
Quark Venture
Quark Venture is an investment firm operating in the Information & Document Management industry. Their participation in MSI Methylation Sciences' funding round suggests a strategic interest in companies advancing scientific research and development.
What's next for MSI Methylation Sciences?
The substantial enterprise-level funding and recent strategic investment position MSI Methylation Sciences for significant growth and development. This capital infusion is likely to accelerate the company's research initiatives, potentially leading to breakthroughs in methylation-based diagnostics or treatments. Furthermore, the backing from investors like Quark Venture suggests a strategic alignment aimed at enhancing the company's market presence and operational capabilities. MSI Methylation Sciences is poised to further its mission in the complex field of methylation science, with future developments expected to capitalize on this robust financial backing.
See full MSI Methylation Sciences company page
